You are here: Industry Insights > Tablets

News List

Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Dr. Reddy's Laboratories Launches Valsartan Tablets, USP in the U.S. Market AmericanPharmaceuticalReview
December 10, 2021
Dr. Reddy’s Laboratories Ltd. announced the launch of Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan® (valsartan) Tablets approved by the U.S. Food and Drug Administration (USFDA).
Mars Remedies requests NAFDAC to remove it from the blacklist expresspharma
October 26, 2020
Gujarat-based Mars Remedies, which was recently blacklisted by the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC), has written a letter to the agency, providing an explanation and requesting the authority to remove it from
BMJ journal deems opioid dependency implant more favourable than tablets pharmatimes
March 30, 2020
A new benefit-risk study published in the BMJ Evidence Based Medicine has deemed a new implant preventing withdrawal symptoms for patients with opioid dependency more favourable than sublingual tablets.
Prescribing Fewer Tablets Can Cut Post-ACL Surgery Opioid Use drugs
July 15, 2019
Prescribing Fewer Tablets Can Cut Post-ACL Surgery Opioid Use.
SunGen Pharma Receives Sixth ANDA Approval from FDA contractpharma
July 10, 2019
Methylprednisolone approved for treatment of arthritis, allergic reactions, and immune system disorders.
Lupin launches generic seizure drug in US expressbpd
May 13, 2019
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug Administration
Teva launches generic version of VESIcare (solifenacin succinate) tablets in US pharmaceutical-business-review
April 24, 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S.
Alvogen, Business Partners Obtain First European Approvals for Generic Ulipristal 5mg americanpharmaceuticalreview
April 11, 2019
Alvogen, Business Partners Obtain First European Approvals for Generic Ulipristal 5mg.
Mettler Toledo Launches SAFELINE X34 contractpharma
November 27, 2018
METTLER TOLEDO has launched SAFELINE X34, a new X-ray inspection system that performs component presence verification for packaged Medical Devices, prescription, and over-the counter medications

Previous page 1 2 Next page